Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tissue Therapies Ltd Issues New Ordinary Shares


Tuesday, 26 Feb 2013 05:38pm EST 

Tissue Therapies Ltd announced that it has issued approximately 21,401,989 fully paid ordinary shares through a 1 for 10 pro- rata non-renounceable Rights Issue. The issue price is AUD 0.21 per share. The funds raised primarily to fund: GMP process validation; health economics and reimbursement studies; inventory manufacturing with labelling for additional markets; other manufacturing, distribution and regulatory costs; sales and marketing pre and post-sales launch; research and development; and operating expenditure. 

Latest Developments for Tissue Therapies Ltd

Company Quote

0.295
0.01 +3.51%
1 Aug 2014